Polyunsaturated fatty acyl-coenzyme As are inhibitors of cholesterol biosynthesis in zebrafish and mice

DMM Disease Models and Mechanisms

Volumn 6, Issue 6, 2013, Pages 1365-1377

  Karanth, Santhosh ^a   Tran, Vy My ^b   Kuberan, Balagurunathan ^b,c   Schlegel, Amnon ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b University of Utah   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A; CARBON; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; ICOSAPENTAENOIC ACID; MEVALONIC ACID; POLYUNSATURATED FATTY ACID; PRAVASTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATOM; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; ENZYME ACTIVITY; FATTY LIVER; IN VITRO STUDY; KETOGENIC DIET; MALE; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DIET; WILD TYPE; ZEBRA FISH;

ANIMALS; CHOLESTEROL; COENZYME A; FATTY ACIDS, UNSATURATED; FATTY LIVER; FISH OILS; KETOGENIC DIET; MICE; ZEBRAFISH;

EID: 84888875599     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.013425     Document Type: Article

References (91)

1. Archer, A., Lauter, G., Hauptmann, G., Mode, A. and Gustafsson, J.-Å. (2008). Transcriptional activity and developmental expression of liver X receptor (lxr) in zebrafish. Dev. Dyn. 237, 1090-1098.
2. Arebalo, R. E., Hardgrave, J. E., Noland, B. J. and Scallen, T. J. (1980). In vivo regulation of rat liver 3-hydroxy-3-methylglutaryl-coenzyme A reductase: enzyme phosphorylation as an early regulatory response after intragastric administration of mevalonolactone. Proc. Natl. Acad. Sci. USA 77, 6429-6433.
3. Ariyama, H., Kono, N., Matsuda, S., Inoue, T. and Arai, H. (2010). Decrease in membrane phospholipid unsaturation induces unfolded protein response. J. Biol. Chem. 285, 22027-22035.
4. Babin, P. J., Thisse, C., Durliat, M., Andre, M., Akimenko, M. A. and Thisse, B. (1997). Both apolipoprotein E and A-I genes are present in a nonmammalian vertebrate and are highly expressed during embryonic development. Proc. Natl. Acad. Sci. USA 94, 8622-8627.
5. Baigent, C., Blackwell, L., Emberson, J., Holland, L. E., Reith, C., Bhala, N., Peto, R., Barnes, E. H., Keech, A., Simes, J. et al.; Cholesterol Treatment Trialists' (CTT) Collaboration (2010). Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 376, 1670-1681.
6. Baigent, C., Landray, M. J., Reith, C., Emberson, J., Wheeler, D. C., Tomson, C., Wanner, C., Krane, V., Cass, A., Craig, J. et al.; SHARP Investigators (2011). The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebocontrolled trial. Lancet 377, 2181-2192.
7. Ballantyne, C. M., Bays, H. E., Kastelein, J. J., Stein, E., Isaacsohn, J. L., Braeckman, R. A. and Soni, P. N. (2012). Efficacy and safety of eicosapentaenoic acid ethyl ester (AMR101) therapy in statin-treated patients with persistent high triglycerides (from the ANCHOR study). Am. J. Cardiol. 110, 984-992.
8. Bang, H. O., Dyerberg, J. and Nielsen, A. B. (1971). Plasma lipid and lipoprotein pattern in Greenlandic West-coast Eskimos. Lancet 297, 1143-1146.
9. Bang, H. O., Dyerberg, J. and Sinclair, H. M. (1980). The composition of the Eskimo food in north western Greenland. Am. J. Clin. Nutr. 33, 2657-2661.
10. Baum, S. J. (2012). EPA and DHA: distinct yet essential n-3 fatty acids. J. Clin. Lipidol. 6, 477, author reply 477-479.
11. Bays, H. E., Ballantyne, C. M., Kastelein, J. J., Isaacsohn, J. L., Braeckman, R. A. and Soni, P. N. (2011). Eicosapentaenoic acid ethyl ester (AMR101) therapy in patients with very high triglyceride levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] trial). Am. J. Cardiol. 108, 682-690.
12. Bertrand, S., Thisse, B., Tavares, R., Sachs, L., Chaumot, A., Bardet, P.-L., Escrivà, H., Duffraisse, M., Marchand, O., Safi, R. et al. (2007). Unexpected novel relational links uncovered by extensive developmental profiling of nuclear receptor expression. PLoS Genet. 3, e188.
13. Bischoff, K. M. and Rodwell, V. W. (1996). 3-Hydroxy-3-methylglutaryl- coenzyme A reductase from Haloferax volcanii: purification, characterization, and expression in Escherichia coli. J. Bacteriol. 178, 19-23.
14. Bitman, J. and Wood, D. L. (1982). An improved copper reagent for quantitative densitometric thin-layer chromatography of lipids. J. Liq. Chromatogr. 5, 1155-1162.
15. Boden, W. E., Probstfield, J. L., Anderson, T., Chaitman, B. R., Desvignes-Nickens, P., Koprowicz, K., McBride, R., Teo, K., Weintraub, W.; AIM-HIGH Investigators (2011). Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N. Engl. J. Med. 365, 2255-2267.
16. Bonds, D. E., Craven, T. E., Buse, J., Crouse, J. R., Cuddihy, R., Elam, M., Ginsberg, H. N., Kirchner, K., Marcovina, S., Mychaleckyj, J. C. et al. (2012). Fenofibrateassociated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience. Diabetologia 55, 1641-1650.
17. Botolin, D., Wang, Y., Christian, B. and Jump, D. B. (2006). Docosahexaneoic acid (22:6,n-3) regulates rat hepatocyte SREBP-1 nuclear abundance by Erk- and 26S proteasome-dependent pathways. J. Lipid Res. 47, 181-192.
18. Boukaftane, Y., Duncan, A., Wang, S., Labuda, D., Robert, M.-F., Sarrazin, J., Schappert, K. and Mitchell, G. A. (1994). Human mitochondrial HMG CoA synthase: liver cDNA and partial genomic cloning, chromosome mapping to 1p12-p13, and possible role in vertebrate evolution. Genomics 23, 552-559.
19. Brown, M. S., Faust, J. R., Goldstein, J. L., Kaneko, I. and Endo, A. (1978). Induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts incubated with compactin (ML-236B), a competitive inhibitor of the reductase. J. Biol. Chem. 253, 1121-1128.
20. Brown, M. S., Goldstein, J. L. and Dietschy, J. M. (1979). Active and inactive forms of 3-hydroxy-3-methylglutaryl coenzyme A reductase in the liver of the rat. Comparison with the rate of cholesterol synthesis in different physiological states. J. Biol. Chem. 254, 5144-5149.
21. Brownsey, R. W., Boone, A. N., Elliott, J. E., Kulpa, J. E. and Lee, W. M. (2006). Regulation of acetyl-CoA carboxylase. Biochem. Soc. Trans. 34, 223-227.
22. Burg, J. S. and Espenshade, P. J. (2011). Regulation of HMG-CoA reductase in mammals and yeast. Prog. Lipid Res. 50, 403-410.
23. Cahill, G. F., Jr (2006). Fuel metabolism in starvation. Annu. Rev. Nutr. 26, 1-22.
24. Constantinides, P. P. and Steim, J. M. (1985). Physical properties of fatty acyl-CoA. Critical micelle concentrations and micellar size and shape. J. Biol. Chem. 260, 7573-7580.
25. Dietschy, J. M. and McGarry, J. D. (1974). Limitations of acetate as a substrate for measuring cholesterol synthesis in liver. J. Biol. Chem. 249, 52-58.
26. Du, C., Sato, A., Watanabe, S., Wu, C.-Z., Ikemoto, A., Ando, K., Kikugawa, K., Fujii, Y. and Okuyama, H. (2003). Cholesterol synthesis in mice is suppressed but lipofuscin formation is not affected by long-term feeding of n-3 fatty acid-enriched oils compared with lard and n-6 fatty acid-enriched oils. Biol. Pharm. Bull. 26, 766-770.
27. Erickson, S. K. and Fielding, P. E. (1986). Parameters of cholesterol metabolism in the human hepatoma cell line, Hep-G2. J. Lipid Res. 27, 875-883.
28. Eslick, G. D., Howe, P. R. C., Smith, C., Priest, R. and Bensoussan, A. (2009). Benefits of fish oil supplementation in hyperlipidemia: a systematic review and meta-analysis. Int. J. Cardiol. 136, 4-16.
29. Faas, F. H., Carter, W. J. and Wynn, J. O. (1977). Unsaturated fatty acyl-CoA inhibition of cholesterol synthesis in vitro. Biochim. Biophys. Acta 487, 277-286.
30. Faas, F. H., Carter, W. J. and Wynn, J. O. (1978). Fatty acyl-CoA inhibition of betahydroxy- beta-methylglutaryl-CoA reductase activity. Biochim. Biophys. Acta 531, 158-166.
31. Fang, L., Green, S. R., Baek, J. S., Lee, S.-H., Ellett, F., Deer, E., Lieschke, G. J., Witztum, J. L., Tsimikas, S. and Miller, Y. I. (2011). In vivo visualization and attenuation of oxidized lipid accumulation in hypercholesterolemic zebrafish. J. Clin. Invest. 121, 4861-4869.
32. Ginsberg, H. N., Elam, M. B., Lovato, L. C., Crouse, J. R., III, Leiter, L. A., Linz, P., Friedewald, W. T., Buse, J. B., Gerstein, H. C., Probstfield, J. et al.; ACCORD Study Group (2010). Effects of combination lipid therapy in type 2 diabetes mellitus. N. Engl. J. Med. 362, 1563-1574.
33. Haa, Y. C. and Barter, P. J. (1982). Differences in plasma cholesteryl ester transfer activity in sixteen vertebrate species. Comp. Biochem. Physiol. 71B, 265-269.
34. Harris, W. S., Ginsberg, H. N., Arunakul, N., Shachter, N. S., Windsor, S. L., Adams, M., Berglund, L. and Osmundsen, K. (1997). Safety and efficacy of Omacor in severe hypertriglyceridemia. J. Cardiovasc. Risk 4, 385-391.
35. Hastings, N., Agaba, M., Tocher, D. R., Leaver, M. J., Dick, J. R., Sargent, J. R. and Teale, A. J. (2001). A vertebrate fatty acid desaturase with Δ 5 and Δ 6 activities. Proc. Natl. Acad. Sci. USA 98, 14304-14309.
36. Helrich, K. C. (1990). Official Methods of Analysis of AOAC. Arlington, VA: AOAC International.
37. Howell, G., 3rd, Deng, X., Yellaturu, C., Park, E. A., Wilcox, H. G., Raghow, R. and Elam, M. B. (2009). N-3 polyunsaturated fatty acids suppress insulin-induced SREBP- 1c transcription via reduced trans-activating capacity of LXRalpha. Biochim. Biophys. Acta 1791, 1190-1196.
38. HPS2-THRIVE Collaborative Group (2013). HPS2-THRIVE randomized placebocontrolled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, prespecified muscle and liver outcomes, and reasons for stopping study treatment. Eur. Heart J. 34, 1279-1291.
39. Huang, Y. S., Smith, R. S., Redden, P. R., Cantrill, R. C. and Horrobin, D. F. (1991). Modification of liver fatty acid metabolism in mice by n-3 and n-6 delta 6-desaturase substrates and products. Biochim. Biophys. Acta 1082, 319-327.
40. Hugo, S. E., Cruz-Garcia, L., Karanth, S., Anderson, R. M., Stainier, D. Y. R. and Schlegel, A. (2012). A monocarboxylate transporter required for hepatocyte secretion of ketone bodies during fasting. Genes Dev. 26, 282-293.
41. Iverson, S. J., Lang, S. L. and Cooper, M. H. (2001). Comparison of the Bligh and Dyer and Folch methods for total lipid determination in a broad range of marine tissue. Lipids 36, 1283-1287.
42. Jacobson, T. A., Glickstein, S. B., Rowe, J. D. and Soni, P. N. (2012a). Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: a review. J. Clin. Lipidol. 6, 5-18.
43. Jacobson, T. A., Glickstein, S. B., Rowe, J. D. and Soni, P. N. (2012b). Authors' reply to commentary entitled EPA and DHA: distinct yet essential n-3 fatty acids. J. Clin. Lipidol. 6, 477-479.
44. Jeon, T.-I. and Osborne, T. F. (2012). SREBPs: metabolic integrators in physiology and metabolism. Trends Endocrinol. Metab. 23, 65-72.
45. Jornayvaz, F. R., Jurczak, M. J., Lee, H.-Y., Birkenfeld, A. L., Frederick, D. W., Zhang, D., Zhang, X.-M., Samuel, V. T. and Shulman, G. I. (2010). A high-fat, ketogenic diet causes hepatic insulin resistance in mice, despite increasing energy expenditure and preventing weight gain. Am. J. Physiol. 299, E808-E815.
46. Kannel, W. B., Dawber, T. R., Friedman, G. D., Glennon, W. E. and McNamara, P. M. (1964). Risk factors in coronary heart disease: an evaluation of several serum lipids as predictors of coronary heart disease: The Framingham Study. Ann. Intern. Med. 61, 888-899.
47. Karanth, S., Lall, S. P., Denovan-Wright, E. M. and Wright, J. M. (2009). Differential transcriptional modulation of duplicated fatty acid-binding protein genes by dietary fatty acids in zebrafish (Danio rerio): evidence for subfunctionalization or neofunctionalization of duplicated genes. BMC Evol. Biol. 9, 219.
48. Keys, A., Aravanis, C., Blackburn, H. W., Van Buchem, F. S., Buzina, R., Djordjević, B. D., Dontas, A. S., Fidanza, F., Karvonen, M. J., Kimura, N. et al. (1966). Epidemiological studies related to coronary heart disease: characteristics of men aged 40-59 in seven countries. Acta Med. Scand. Suppl. 460, 1-392.
49. Kinkel, M. D., Eames, S. C., Philipson, L. H. and Prince, V. E. (2010). Intraperitoneal injection into adult zebrafish. J. Vis. Exp. 2126.
50. Komura, H. and Iwaki, M. (2008). Species differences in in vitro and in vivo small intestinal metabolism of CYP3A substrates. J. Pharm. Sci. 97, 1775-1800.
51. Kuroda, M. and Endo, A. (1976). Inhibition of in vitro cholesterol synthesis by fatty acids. Biochim. Biophys. Acta 486, 70-81.
52. Lagace, T. A. and Ridgway, N. D. (2013). The role of phospholipids in the biological activity and structure of the endoplasmic reticulum. Biochim. Biophys. Acta 1833, 2499-2510.
53. Leblanc, P. J. and Ballantyne, J. S. (2000). Novel aspects of the activities and subcellular distribution of enzymes of ketone body metabolism in the liver and kidney of the goldfish, Carassius auratus. J. Exp. Zool. 286, 434-439.
54. Lehrer, G., Panini, S. R., Rogers, D. H. and Rudney, H. (1981). Modulation of rat liver 3-hydroxy-3-methylglutaryl coenzyme A reductase by lipid inhibitors, substrates, and cytosolic factors. J. Biol. Chem. 256, 5612-5619.
55. Li, Y. and Watkins, B. A. (2001). Analysis of fatty acids in food lipids. In Current Protocols in Food Analytical Chemistry. John Wiley & Sons, Inc.
56. Lieschke, G. J. and Currie, P. D. (2007). Animal models of human disease: zebrafish swim into view. Nat. Rev. Genet. 8, 353-367.
57. Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y. et al. (2012). Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2095-2128.
58. Maki, K. C., Orloff, D. G., Nicholls, S. J., Dunbar, R. L., Roth, E. M., Curcio, D., Johnson, J., Kling, D. and Davidson, M. H. (2013). A highly bioavailable omega-3 free fatty acid formulation improves the cardiovascular risk profile in high-risk, statintreated patients with residual hypertriglyceridemia (the ESPRIT Trial). Clin. Ther. 9, 1400-1411.
59. Marza, E., Barthe, C., André, M., Villeneuve, L., Hélou, C. and Babin, P. J. (2005). Developmental expression and nutritional regulation of a zebrafish gene homologous to mammalian microsomal triglyceride transfer protein large subunit. Dev. Dyn. 232, 506-518.
60. Mater, M. K., Thelen, A. P., Pan, D. A. and Jump, D. B. (1999). Sterol response element-binding protein 1c (SREBP1c) is involved in the polyunsaturated fatty acid suppression of hepatic S14 gene transcription. J. Biol. Chem. 274, 32725-32732.
61. Mathias, M. M., Sullivan, A. C. and Hamilton, J. G. (1981). Fatty acid and cholesterol synthesis from specifically labeled leucine by isolated rat hepatocytes. Lipids 16, 739-743.
62. Meyer, B. J., Hammervold, T., Rustan, A. C. and Howe, P. R. (2007). Dose-dependent effects of docosahexaenoic acid supplementation on blood lipids in statin-treated hyperlipidaemic subjects. Lipids 42, 109-115.
63. Minkler, P. E., Kerner, J., Ingalls, S. T. and Hoppel, C. L. (2008). Novel isolation procedure for short-, medium-, and long-chain acyl-coenzyme A esters from tissue. Anal. Biochem. 376, 275-276.
64. National Research Council (1993). Nutritional Requirements of Fish. Washington, DC: National Academic Press.
65. Oka, T., Nishimura, Y., Zang, L., Hirano, M., Shimada, Y., Wang, Z., Umemoto, N., Kuroyanagi, J., Nishimura, N. and Tanaka, T. (2010). Diet-induced obesity in zebrafish shares common pathophysiological pathways with mammalian obesity. BMC Physiol. 10, 21.
66. Owen, J. L., Zhang, Y., Bae, S.-H., Farooqi, M. S., Liang, G., Hammer, R. E., Goldstein, J. L. and Brown, M. S. (2012). Insulin stimulation of SREBP-1c processing in transgenic rat hepatocytes requires p70 S6-kinase. Proc. Natl. Acad. Sci. USA 109, 16184-16189.
67. Parkkila, S., Vullo, D., Maresca, A., Carta, F., Scozzafava, A. and Supuran, C. T. (2012). Serendipitous fragment-based drug discovery: ketogenic diet metabolites and statins effectively inhibit several carbonic anhydrases. Chem. Commun. 48, 3551-3553.
68. Powell, G. L., Grothusen, J. R., Zimmerman, J. K., Evans, C. A. and Fish, W. W. (1981). A re-examination of some properties of fatty acyl-CoA micelles. J. Biol. Chem. 256, 12740-12747.
69. Pownall, H. J., Brauchi, D., Kilinç, C., Osmundsen, K., Pao, Q., Payton-Ross, C., Gotto, A. M., Jr and Ballantyne, C. M. (1999). Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins. Atherosclerosis 143, 285-297.
70. Reinhart, K. M. and Woods, J. A. (2012). Strategies to preserve the use of statins in patients with previous muscular adverse effects. Am. J. Health Syst. Pharm. 69, 291-300.
71. Roitelman, J. and Shechter, I. (1989). Studies on the catalytic site of rat liver HMGCoA reductase: interaction with CoA-thioesters and inactivation by iodoacetamide. J. Lipid Res. 30, 97-107.
72. Rombouts, I., Lamberts, L., Celus, I., Lagrain, B., Brijs, K. and Delcour, J. A. (2009). Wheat gluten amino acid composition analysis by high-performance anionexchange chromatography with integrated pulsed amperometric detection. J. Chromatogr. A 1216, 5557-5562.
73. Roncaglioni, M. C., Tombesi, M., Avanzini, F., Barlera, S., Caimi, V., Longoni, P., Marzona, I., Milani, V., Silletta, M. G., Tognoni, G. et al.; Risk and Prevention Study Collaborative Group (2013). n-3 fatty acids in patients with multiple cardiovascular risk factors. N. Engl. J. Med. 368, 1800-1808.
74. Ruiz, J. I. and Ochoa, B. (1997). Quantification in the subnanomolar range of phospholipids and neutral lipids by monodimensional thin-layer chromatography and image analysis. J. Lipid Res. 38, 1482-1489.
75. Sadler, K. C., Rawls, J. F. and Farber, S. A. (2013). Getting the inside tract: new frontiers in zebrafish digestive system biology. Zebrafish 10, 129-131.
76. Schlegel, A. (2012). Studying non-alcoholic fatty liver disease with zebrafish: a confluence of optics, genetics, and physiology. Cell. Mol. Life Sci. 69, 3953-3961.
77. Schlegel, A. and Stainier, D. Y. (2006). Microsomal triglyceride transfer protein is required for yolk lipid utilization and absorption of dietary lipids in zebrafish larvae. Biochemistry 45, 15179-15187.
78. Sekiya, M., Yahagi, N., Matsuzaka, T., Najima, Y., Nakakuki, M., Nagai, R., Ishibashi, S., Osuga, J., Yamada, N. and Shimano, H. (2003). Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression. Hepatology 38, 1529-1539.
79. Shimazu, T., Hirschey, M. D., Newman, J., He, W., Shirakawa, K., Le Moan, N., Grueter, C. A., Lim, H., Saunders, L. R., Stevens, R. D. et al. (2013). Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 339, 211-214.
80. Stoletov, K., Fang, L., Choi, S.-H., Hartvigsen, K., Hansen, L. F., Hall, C., Pattison, J., Juliano, J., Miller, E. R., Almazan, F. et al. (2009). Vascular lipid accumulation, lipoprotein oxidation, and macrophage lipid uptake in hypercholesterolemic zebrafish. Circ. Res. 104, 952-960.
81. Taketa, K. and Pogell, B. M. (1966). The effect of palmityl coenzyme A on glucose 6- phosphate dehydrogenase and other enzymes. J. Biol. Chem. 241, 720-726.
82. Tocher, D. R., Agaba, M., Hastings, N., Bell, J. G., Dick, J. R. and Teale, A. J. (2001). Nutritional regulation of hepatocyte fatty acid desaturation and polyunsaturated fatty acid composition in zebrafish (Danio rerio) and tilapia (Oreochromis niloticus). Fish Physiol. Biochem. 24, 309-320.
83. Tubbs, P. K. and Garland, P. B. (1964). Variations in tissue contents of coenzyme A thio esters and possible metabolic implications. Biochem. J. 93, 550-557.
84. Wilson, J. M., Bunte, R. M. and Carty, A. J. (2009). Evaluation of rapid cooling and tricaine methanesulfonate (MS222) as methods of euthanasia in zebrafish (Danio rerio). J. Am. Assoc. Lab. Anim. Sci. 48, 785-789.
85. Worgall, T. S., Sturley, S. L., Seo, T., Osborne, T. F. and Deckelbaum, R. J. (1998). Polyunsaturated fatty acids decrease expression of promoters with sterol regulatory elements by decreasing levels of mature sterol regulatory element-binding protein. J. Biol. Chem. 273, 25537-25540.
86. Xu, J., Nakamura, M. T., Cho, H. P. and Clarke, S. D. (1999). Sterol regulatory element binding protein-1 expression is suppressed by dietary polyunsaturated fatty acids. A mechanism for the coordinate suppression of lipogenic genes by polyunsaturated fats. J. Biol. Chem. 274, 23577-23583.
87. Yahagi, N., Shimano, H., Hasty, A. H., Amemiya-Kudo, M., Okazaki, H., Tamura, Y., Iizuka, Y., Shionoiri, F., Ohashi, K., Osuga, J.-i. et al. (1999). A crucial role of sterol regulatory element-binding protein-1 in the regulation of lipogenic gene expression by polyunsaturated fatty acids. J. Biol. Chem. 274, 35840-35844.
88. Yamato, S., Shinohara, K., Nakagawa, S., Kubota, A., Inamura, K., Watanabe, G., Hirayama, S., Miida, T. and Ohta, S. (2009). High-performance liquid chromatography determination of ketone bodies in human plasma by precolumn derivatization with p-nitrobenzene diazonium fluoroborate. Anal. Biochem. 384, 145-150.
89. Yin, W., Carballo-Jane, E., McLaren, D. G., Mendoza, V. H., Gagen, K., Geoghagen, N. S., McNamara, L. A., Gorski, J. N., Eiermann, G. J., Petrov, A. et al. (2012). Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia. J. Lipid Res. 53, 51-65.
90. Yoshikawa, T., Shimano, H., Yahagi, N., Ide, T., Amemiya-Kudo, M., Matsuzaka, T., Nakakuki, M., Tomita, S., Okazaki, H., Tamura, Y. et al. (2002). Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements. J. Biol. Chem. 277, 1705-1711.
91. Zahler, W. L., Barden, R. E. and Cleland, W. W. (1968). Some physical properties of palmityl-coenzyme A micelles. Biochim. Biophys. Acta 164, 1-11.